FOR EU/EEA HEALTHCARE PROFESSIONALS ONLY Celgene Corporation would like to introduce an EU / EEA mobile dosing app for ABRAXANE® (paclitaxel formulated as albumin bound nanoparticles). Recommended doses and modifications for both EU / EEA approved indications for ABRAXANE can be found within this mobile app. The dosing recommendations are based on the Prescribing Information for ABRAXANE. Also included is an overview of the trial design for each indication, including treatment arms, study dose, and patient population. Please see full Prescribing Information, including Boxed WARNING for ABRAXANE at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000778/WC500020435.pdf This App is not a medical device, but intended for use as an educational tool. ©2014 Celgene Corporation. All rights reserved. Date of preparation May 2014. less
|
